99.96% effective against CRE (Klebsiella pneumoniae)

99.96% effective against CRE (Klebsiella pneumoniae)

In light of recent media coverage about another drug-resistant “superbug” and our concern as a business about antimicrobial resistance, BioCote Ltd has commissioned testing of our antimicrobial technology against a carbapenem-resistant Enterobacteria (CRE). The independently-performed ISO 22196 test demonstrated elimination of over 99.9% of the bacterium Klebsiella pneumoniae.

bacteria-reduction-with-hygienic-pvc

Learn more by visiting our antimicrobial partner’s website

< Back